Add BrightSurf on Google Email

NIH/National Institute of Neurological Disorders and Stroke


NIH researchers link cases of ALS and FTD to a Huntington's disease-associated mutation

Researchers have discovered a genetic connection between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), with the same huntingtin mutation associated with Huntington's disease. The study opens up possibilities for gene therapy targeting this mutation, which could lead to personalized medicine.

Turning off 'junk DNA' may free stem cells to become neurons

A new NIH study suggests that deactivating certain genes in the human genome may play a role in controlling the differentiation of stem cells into neurons. The research found that these genes, which were once thought to be inactive 'junk DNA', may help regulate the maturation process of stem cells, leading to improved understanding of ...

SourceNIH/National Institute of Neurological Disorders and Stroke·JournalProceedings of the National Academy of Sciences·DateJul 13, 2020

NIH BRAIN Initiative tool helps researchers watch neural activity in 3D

The NIH BRAIN Initiative's SCAPE microscopy technique allows researchers to observe large volumes of tissue in 3D, revealing more complex interactions between nerve cells responding to mixed odors. This breakthrough has implications for understanding how the brain perceives smells and may lead to new treatments for neurological disorders.

Study finds differences in energy use by immune cells in ME/CFS

Researchers discovered that specific immune T cells from people with ME/CFS exhibit disruptions in energy production, suggesting changes in the immune system. The study found decreased levels of glycolysis and mitochondrial function in affected cells, potentially providing clues to understanding the mechanisms underlying ME/CFS.

SourceNIH/National Institute of Neurological Disorders and Stroke·JournalJournal of Clinical Investigation·DateDec 12, 2019

Study finds three anti-seizure drugs equally effective for severe form of epilepsy

A new study has found that levetiracetam, fosphenytoin, and valproate are equally safe and effective in treating patients with refractory status epilepticus. The three drugs were tested on over 380 children and adults, showing similar benefits in stopping seizures and improving responsiveness.

SourceNIH/National Institute of Neurological Disorders and Stroke·JournalNew England Journal of Medicine·DateNov 27, 2019

Pathogenic tau and cognitive impairment are precipitated by a high-salt diet

A high-salt diet can cause cognitive impairment by activating a pathway in the brain that leads to tau protein clumping, according to a new study. The researchers found that this effect is not due to a loss in blood flow to the brain, but rather to the accumulation of tau protein aggregates that interfere with brain cell function.

Releasing an immune system brake could help patients with rare but fatal brain infection

A small-scale NIH-led clinical study found that pembrolizumab can slow or stop the progression of progressive multifocal leukoencephalopathy (PML), a fatal brain infection caused by the JC virus. The treatment resulted in improved symptoms and reduced viral levels in five patients with PML.

SourceNIH/National Institute of Neurological Disorders and Stroke·JournalNew England Journal of Medicine·DateApr 10, 2019

Study identifies gene that makes gentle touch feel painful after injury

Researchers identified PIEZO2 as a gene controlling tactile allodynia, a form of pain caused by gentle touch after injury. The study found that PIEZO2 plays an essential role in the nervous system's reaction to injury and inflammation, making it a target for developing precise treatments for relieving painful skin injuries.

SourceNIH/National Institute of Neurological Disorders and Stroke·JournalScience Translational Medicine·DateOct 10, 2018